International Society for antiviral research

Home
ICAR2022
Detailed Schedule

Detailed program Schedule

Click here to view detailed program with invited and short oral speakers.

*All times are listed in US Pacific time

Monday, March 21, 2022
11:15 AM - 11:45 AM PT	Speed Networking (Via the Virtual Platform)
12:00 PM - 1:45 PM PT	Special Event: Women in Science Roundtable (In-Person Event Only)
2:00 PM - 4:15 PM PT	Opening Session and Plenary Speakers Chaired by Kara Carter and Kathie Seley-Radtke Ken Duncan, Bill & Melinda Gates Foundation What Role Can Foundations Play in Driving Innovation Globally in Antiviral Development? Carl W. Dieffenbach, National Institute of Allergy and Infectious Diseases, National Institutes of Health Drug Development for Viruses of Pandemic Potential, Where Are We Now and Where Are We Going?
4:15 PM - 4:30 PM PT	Break
4:30 PM - 5:30 PM PT	Gertrude Elion Memorial Award Lecture Chaired by Kara Carter and Kathie Seley-Radtke George Painter, Emory University School of Medicine, Emory Institute of Drug Development, and Drug Innovation Ventures at Emory 2022 Gertrude Elion Memorial Award Recipient Developing an Oral Antiviral Agent in a Pandemic: The Evolution of Molnupiravir (EIDD-2801, MK-4482) as a Treatment for COVID-19
5:30 PM - 6:30 PM PT	Opening Reception (In-Person Event Only)

Tuesday, March 22, 2022
8:30 AM - 9:15 AM PT	Antonín Holý Memorial Award Lecture Chaired by Kathie Seley-Radtke and Andrea Brancale *Mark von Itzstein, Institute for Glycomics at Griffith University 2022 Antonín Holý Award Recipient* *Structure-guided Antiviral Drug Discovery – A Tale of Two Viruses*
9:15 AM - 11:00 AM PT	Non-coronavirus Respiratory Viruses Chaired by Kathie Seley-Radtke and Mark von Itzstein Anne Moscona, Columbia University Vagelos College of Physicians & Surgeons Inhibiting Entry of Human Paramyxoviruses *Ralf Altmeyer, Medusa Therapeutics Limited Inducing Phase Transition in Viral Condensates. A Novel Antiviral Strategy* Additional short presentations
10:15 AM - 10:30 AM PT	Break
11:00 AM - 12:00 PM PT	PechaKucha Competition
1:30 PM - 2:15 PM PT	William Prusoff Memorial Award Lecture Chaired by Kara Carter and Kathie Seley-Radtke Priscilla Yang, Stanford University School of Medicine 2022 William Prusoff Memorial Award Recipient Targeted Protein Degradation as an Antiviral Strategy
2:15 PM - 5:00 PM PT	Retroviruses and Other Viruses Chaired by Chris Meier and Brian Gentry Shan-Lu Liu, The Ohio State University Cell-to-Cell Transmission by Emerging Viruses: Mechanisms of Action and Evasion of Host Immunity Christian Callebaut, Gilead Sciences Lenacapavir: The First Clinically Active Long-Acting Inhibitor of HIV Capsid Lisa Oestereich, Bernhard-Nocht-Institut for Tropical Medicine Antiviral Therapy for Lassa Fever Additional short presentations George F. Gao, Institute of Microbiology, Chinese Academy of Sciences Monoclonal Antibodies Against Both Flu and RSV
3:45 PM - 4:00 PM PT	Break
5:00 PM - 7:00 PM PT	Poster Session 1 (In-Person Event Only) Light food and beverages provided

Wednesday, March 23, 2022
8:30 AM - 9:15 AM PT	Antonín Holý Memorial Award Lecture Chaired by Kara Carter and Chris Meier Kathie Seley-Radtke, University of Maryland Baltimore County (UMBC) 2020 Antonín Holý Award Recipient Fleximers – A Strategic Approach to Broad-Spectrum Antiviral Therapeutics
9:15 AM - 12:15 PM PT	Broad Spectrum Antiviral Drugs and Pandemic Preparedness Chaired by John Bilello and* Priscilla Yang* Marco Vignuzzi, Infectious Diseases Labs ID Labs, AStar Out of the Box: 20 Years of Targeting Virus Infections Unconventionally* Rolf Hilgenfeld, University of Lübeck, Institute of Molecular Medicine The SARS-CoV-2 Main Protease: New Inhibitors, Crystal Structures, and Mutations Jeffrey Glenn, Stanford University School of Medicine Host-Targeting Broad-Spectrum Antivirals for Pandemic Preparedness Additional short presentations
10:15 AM - 10:30 AM PT	Break
12:15 PM - 1:00 PM PT	Late-breaking Oral Presentations Chaired by Luis Schang and Jerome Deval
1:00 PM - 3:00 PM PT	Poster Session 2 (In-Person Event Only) Lunch provided

Thursday, March 24, 2022
8:30 AM - 9:15 AM PT	Women in Science Award Lecture Chaired by Rhonda Cardin and Jennifer Moffat Christina Spiropoulou, US Centers for Disease Control and Prevention 2022 Women in Science Speaker Award Recipient Fighting Viral Hemorrhagic Fevers: From the Benches to the Trenches
9:15 AM - 12:00 PM PT	Arboviruses Chaired by Andrea Brancale and Justin Julander Leen Delang, KU Leuven Antiviral Strategies for Arboviruses: A ‘Buzzing’ Role for the Mosquito Vector? Amy Hartman, University of Pittsburgh Graduate School of Public Health New Insights into Cellular Infection by the Mosquito-Transmitted Rift Valley Fever Virus Feng Gu, Novartis Institute for Tropical Diseases NITD-688, a Pan-Serotype Inhibitor of the Dengue Virus NS4B Protein, Shows Favorable Pharmacokinetics and Efficacy in Preclinical Animal Models Additional short presentations
10:15 AM - 10:30 AM PT	Break
12:00 PM - 12:15 PM PT	ISAR Annual Business Meeting
2:00 PM - 2:45 PM PT	Diversity Speaker Award Lecture Chaired by Craig Cameron and Kara Carter J. Victor Garcia-Martinez, University of North Carolina, Chapel Hill 2022 Diversity Speaker Award Recipient The COVID-19 Pandemic: A View from the Bench
2:45 PM - 5:45 PM PT	Coronaviruses Chaired by Craig Cameron and Kara Carter Sara Cherry, University of Pennsylvania Pyrimidine Inhibitors Synergize with Nucleoside Analogues to Block SARS-CoV-2 David Dulin, Vrije Universiteit Amsterdam, Faculty of Sciences/Division of Physics and Astronomy Mechanochemistry and Drug Targeting of the SARS-CoV-2 Replication-Transcription Complex from a Single Molecule Perspective Uri Lopatin, Pardes Biosciences Profile of PBI-0451 an Orally Administered 3CL Protease Inhibitor of SARS-CoV-2 for COVID-19 Additional short presentations
3:45 PM - 4:00 PM PT	Break
7:00 PM - 10:00 PM PT	Closing Dinner Event (In-Person Event Only)

Friday, March 25, 2022
8:30 AM - 9:30 AM PT	Special Event: Career Development Interactive Workshop Chaired by Leen Delang and Brian Gowen Harmit Malik, Fred Hutchinson Cancer Research Center The Power of Mentoring
9:30 AM - 12:00 PM PT	Hepatitis and Herpes Viruses Chaired by Jerome Deval and Roger Ptak Fabien Zoulim, Hospices Civils de Lyon, INSERM Unit 1052 Clinical Update on Viral RNA Targeting Agents for Chronic Hepatitis B William Delaney, Assembly Bio Discovery and Development of HBV Core Inhibitors for the Treatment of Chronic Hepatitis B Infection Pinghui Feng, University of Southern California, Herman Ostrow School of Dentistry Explore Viral Infection to Probe Roles of Protein Deamidation Additional short presentations
10:30 AM - 10:45 AM PT	Break
12:00 PM - 12:30 PM PT	Shotgun Presentations and Closing Remarks

About ISAR

The International Society for Antiviral Research (ISAR) is an internationally recognized organization for scientists involved in basic, applied, and clinical aspects of antiviral research. The Society main event is the annual International Conference on Antiviral Research (ICAR), a truly interdisciplinary meeting which attracts the interest of chemists, biologists, and clinicians.

ISAR

info@isaricar.com
1-571-349-0079